SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Closure Medical (CLSR) fomerly Tri-Point Medical (TPMC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RevMikeB who wrote (125)3/21/1998 5:42:00 PM
From: David S.  Read Replies (1) of 184
 
Closure has a 1st generation "glue". There are other companies that are behind closure in the approval process, but who believe they have a better product. If those other firms are correct, then closure's future big earnings that is projected would not occur, since 3 or 4 years from now, they will have several competitors, and we should think competitors with better products. My understanding is that the company has problems with infection rates being too high. I suspect that over the next few months, more information about competitive products will surface.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News